Neurimpulse’s mission is improve patient’s quality of life suffering from chronic pain trough the permanent implantable neuromodulation.
For your practice For your patient's health
Efficacy at the best
Minimal size to preserve aesthetics
Lower risk of complication
Increased device longevity
80% of treated patients confirm the benefit during the trial phase
PUBLICATIONS RELATING TO CLINICAL STUDIES ON THE SYSTEM
LIGHTPULSE 100L is a tetrapolar non rechargeable (primary cell) neurostimulator that is part of a peripheral nerve stimulation system, for which has been specifically designed. LIGHTPULSE 100L is indicated for the treatment of chronic pain by the stimulation of peripheral nerve. The neurostimulator is equipped by an in line connector with four electrodes and it accommodates one bipolar or tetrapolar lead of Neurimpulse families.
The LIGHT MASTER 200 is the new programmer dedicated to neurostimulators of the Neurimpulse family. Equipped with a simple and intuitive user interface, it supports the doctor in the management of patients with chronic pain.
TL300ADA adapter cable is designed to be used in the temporary implantation connecting the trial stimulator TESTER LIFE 300, NEURIMPULSE leads or extensions.
The FIXLINE family includes a series of tetrapolar leads especially designed for treatment and control of chronic pain to be used in association with the stimulators manufactured by Neurimpulse. FIXLINE leads have excellent mechanical proprieties of strength and flexibility so they can be used in high stress environment ( like on brachial plexus ).
The length of the lead may be increased by using an extension with compatible connection. The extensions of the neurological LSL family, were designed to ensure a reliable and durable electrical stimulation for the treatment and control of chronic pain, combining excellent mechanical strength and flexibility.
Light Solutions for chronic pain
Neurimpulse born from the idea of treating neuropathic pain by direct nerve stimulation, close to the painful area.
Focusing terapy to upper and lower limbs, our company benefits from decades of experience and professionalism in the field of electrostimulation with implantable devices.
The first CE mark was released by the notified body 0373 in 2009 for Lightline leads family. Subsequently, in 2010, the CE mark was also obtained for the implantable stimulator, temporary stimulator, programmer for the doctor and programmer for the patient in addition to the various leads, extensions and accessories.
Currently, all neurostimulation products have CE mark, confirming that Research and Development, Production, Post-Marketing, Quality Assurance and the other departments that interact in the internal process carry out their activities in accordance with the dispositions established by European Union, in particular the directive 90/385/EEC and subsequent changes and additions.
Our target is the treatment of pain related to peripheral neuropathies.
WHAT CAN WE DO FOR YOU?
For more information or for technical support, please CONTACT US